Heron Therapeutics Inc (HRTX)
1.07
+0.01
(+0.94%)
USD |
NASDAQ |
Nov 22, 16:00
1.07
0.00 (0.00%)
After-Hours: 18:49
Heron Therapeutics Price: 1.07 for Nov. 22, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 21, 2024 | 1.10 | 1.12 | 1.05 | 1.06 | 1.571M |
Nov 20, 2024 | 1.195 | 1.195 | 1.10 | 1.12 | 1.729M |
Nov 19, 2024 | 1.14 | 1.205 | 1.11 | 1.19 | 2.136M |
Nov 18, 2024 | 1.19 | 1.215 | 1.13 | 1.17 | 1.393M |
Nov 15, 2024 | 1.25 | 1.255 | 1.15 | 1.19 | 1.499M |
Nov 14, 2024 | 1.22 | 1.34 | 1.21 | 1.24 | 2.552M |
Nov 13, 2024 | 1.31 | 1.36 | 1.18 | 1.21 | 2.846M |
Nov 12, 2024 | 1.04 | 1.53 | 1.04 | 1.28 | 10.61M |
Nov 11, 2024 | 1.74 | 1.895 | 1.74 | 1.84 | 2.568M |
Nov 08, 2024 | 1.77 | 1.79 | 1.72 | 1.75 | 1.101M |
Nov 07, 2024 | 1.80 | 1.85 | 1.755 | 1.77 | 1.207M |
Nov 06, 2024 | 1.80 | 1.85 | 1.77 | 1.80 | 1.138M |
Nov 05, 2024 | 1.77 | 1.77 | 1.70 | 1.77 | 958215.0 |
Nov 04, 2024 | 1.80 | 1.85 | 1.75 | 1.78 | 1.005M |
Nov 01, 2024 | 1.75 | 1.805 | 1.745 | 1.78 | 911137.0 |
Oct 31, 2024 | 1.80 | 1.81 | 1.70 | 1.74 | 1.199M |
Oct 30, 2024 | 1.74 | 1.845 | 1.73 | 1.80 | 1.473M |
Oct 29, 2024 | 1.88 | 1.885 | 1.76 | 1.77 | 2.318M |
Oct 28, 2024 | 1.85 | 1.995 | 1.85 | 1.91 | 1.766M |
Oct 25, 2024 | 1.78 | 1.885 | 1.77 | 1.85 | 1.707M |
Oct 24, 2024 | 1.79 | 1.82 | 1.73 | 1.78 | 1.011M |
Oct 23, 2024 | 1.78 | 1.825 | 1.73 | 1.80 | 1.401M |
Oct 22, 2024 | 1.79 | 1.81 | 1.70 | 1.78 | 1.733M |
Oct 21, 2024 | 1.75 | 1.81 | 1.72 | 1.81 | 1.779M |
Oct 18, 2024 | 1.82 | 1.854 | 1.76 | 1.76 | 862842.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.54
Minimum
Nov 14 2023
26.61
Maximum
Dec 03 2019
8.449
Average
4.67
Median
Sep 16 2022
Price Benchmarks
Journey Medical Corp | 5.30 |
NovaBay Pharmaceuticals Inc | 0.6855 |
Palatin Technologies Inc | 0.9589 |
iBio Inc | 2.64 |
Theriva Biologics Inc | 1.29 |
Price Related Metrics
PS Ratio | 1.180 |
Earnings Yield | -14.95% |
Market Cap | 162.74M |